Welcome - Welkom
Annual General Meeting of Shareholders
Algemene Vergadering van
Aandeelhouders
The Hague, May 15, 2020
Helping people achieve a lifetime of financial security
William L. Connelly
Chairman of the Supervisory Board
Voorzitter van de Raad van Commissarissen
2
Welcome to the Annual | Welkom bij de jaarlijkse |
General Meeting of | Algemene Vergadering van |
Shareholders | Aandeelhouders |
3
Agenda item 1 │ Agendapunt 1
OpeningOpening
This item will not be voted upon / Over dit agendapunt wordt niet gestemd | 4 | |
Agenda item 2 │ Agendapunt 2
2019 | Presentatie over de gang |
Business overview | van zaken in 2019 |
This item will not be voted upon / Over dit agendapunt wordt niet gestemd | 5 | |
Living up to our purpose in testing times
Alex Wynaendts
CEO & Chairman of the Executive Board
The Hague, May 15, 2020
Helping people achieve a lifetime of financial security
Today's storyline
- Impact ofCOVID-19
- People
- Customers
- Operations
- Financials
- Briefly looking back on 2019
- Focus on growth and capital
- Active portfolio management
- Financial highlights
- Living up to our purpose
7
We are living in testing times
With huge impact on customers and employees
- COVID-19impacts:
- People
- Operations
- Customers
- Financials
- Main responsibilities:
- Ensuring safety of our employees
- Fulfilling promises to our customers by maintaining strong capital position
- Supporting our communities
8
Our response to COVID-19 crisis
Health and safety of employees primary responsibility; continued operations
- Crisis management
- Effective crisis management governance in place; global guidance - local implementation
- Working from home
- Stable working from home environment was enabled for all our employees across the world
- Engagement
- Global framework introduced to sustainwell-being, engagement and productivity of employees
- Continuity of critical services ensured
- While working from home
- Business continuity of critical outsourcing partners
- Shown to be robust
- Enhancing use of digital solutions
- For answering customer questions
9
Our response to COVID-19 crisis
Providing guidance and financial relief to our customers
•Ensuring uninterrupted customer service
−Increased customer appraisal
- No material pandemic exclusions
- After outbreak,COVID-19 coverage included in critical illness product China
- Providing premium payment and fee
flexibility
- Case-by-caseapproach for insurance, pensions and mortgages
- Offering relevant solutions and advice
- Launch oftele-health in Spain and Portugal providing 24 hrs. medical advice for free
10
Our response to COVID-19 crisis
Supporting our communities
- Our businesses responded with local initiatives for immediate support
- For a total of over EUR 1 million to date
- Initiatives include:
US:providing protective gear to frontline healthcare workers
Across Europe:donating medical supplies and food to the elderly and helping supply protective gear to healthcare workers
UK:dedicated corporate donation for local charity to be decided by employees
NL:support healthcare workers | Asia:supporting |
insurance; laptops for children | hospitals and relief |
for home schooling | and developments |
organizations, | |
supplying personal | |
protective equipment | |
and promoting health | |
education |
11
Execution of strategy in 2019
- Environment remained challenging
- Persistent low interest rates in our key markets
- Customers impacted by economic uncertainty
- Growing need for solidarity and financial security
- Further simplified our organization
- Reorganization of US businesses
- Aegon International launched
- Investing in the future
- Responsible business
- Leveraging technology
- Build-upanalytics capabilities
12
Continued focus on growth and capital in 2019
•Improved commercial momentum while we continued to invest in customer services
- Increase in Life, Accident & Health sales and gross deposits during the year
•Capturing opportunities in fast-growing markets
−Financial protection and investment management in India and China
•Strong normalized capital generation of EUR 1.6 billion over 2019
−Up 12% compared with 2018
•Solid Group Solvency II ratio of 201% per year-end 2019
−All business units also strongly capitalized
13
Successfully optimizing our portfolio
Underlying earnings before tax(in EUR million, FY2019)
Manage for Value | Drive for Growth | ||||
•Reinsured a quarter of longevity risk in | •Positive momentum in Life and Accident | ||||
the Netherlands | & Health sales, as well as gross deposits | ||||
• | New own employee pension plan protects | 35% | € 1,973 | •Eighth consecutive full year of positive | |
capital position and reduces volatility | 55% | external third-party net inflows for Aegon | |||
million | |||||
• | Successful transfer of policy | Asset Management | |||
administration to Atos in the UK | •Realized targeted expense savings from | ||||
10% | Cofunds integration |
Scale-up for Future
- Continue expanding our digital platforms
- New partnership with a largee-commerce player in China, driving sales growth
- Agreed partnership with leading mobile wallet MobiKwik in India to launch smart digital insurance product
•Completed divestment of variable annuity joint ventures in Japan | 14 |
Purpose more relevant than ever before
As already recognized 175 years ago
Purpose | Helping people achieve a lifetime of |
financial security | |
- Strategic transformation
Transformation•Financial transformation
- Organizational & cultural transformation
Financial | • | Solid balance sheet |
strength | • | Strong liquidity position |
To continue to live up to our purpose - also in
these testing times
15
Agenda item 3 │ Agendapunt 3
Annual Report and | Jaarverslag en |
Annual Accounts 2019 | jaarrekening 2019 |
16
Agenda item 3.1 │ Agendapunt 3.1
Reports of the Boards | Verslagen van de |
for 2019 | Raad van Bestuur en de |
Raad van Commissarissen | |
over 2019 |
This item will not be voted upon / Over dit agendapunt wordt niet gestemd | 17 | |
Our financial performance in 2019
Matt Rider
CFO & Member of the Executive Board
The Hague, May 15, 2020
Helping people achieve a lifetime of financial security
Today's storyline
- Financial highlights 2019
- Key performance indicators 1Q 2020
- Balance sheet preservation
- Target outlook
19
Financial highlights 2019
IFRS | Capital position |
per year-end |
Underlying earnings | Group solvency ratio |
EUR 1,973 million | 201% |
-5% compared with 2018 | -10pp compared with 2018 |
Net income | Holding excess cash |
EUR 1,528 million | EUR 1,192 million |
Up EUR 784 million from 2018 | Within target range |
Return on equity | Gross financial leverage |
9.5% | 28.5% |
-70bp compared with 2018 | -70bp compared with 2018 |
Capital generation and
dividend
Capital generation1
EUR 1,569 million
+12% compared with 2018
Gross remittances
to holding
EUR 1,365 million2
Dividend per share3
EUR 0.15
1. Capital generation excluding market impact and one-time items after holding funding & operation expenses | 20 |
- Excludes EUR 100 million remittances by Aegon the Netherlands to the Group in February 2020; EUR 1,518 million including sale of stake in Japan JVs
- On April 2, 2020, EIOPA and DNB published statements urging insurers to temporarily postpone all dividend distributions. Proposed final 2019 dividend of EUR 0.16 per share was subsequently cancelled on April 3, 2020
Our key performance indicators in 1Q 2020
Underlying earnings | Net income | Normalized capital | Group Solvency II | Holding excess |
before tax | generation | ratio | cash | |
€ 366 million | € 1,270 million | € 311 million | 208% | € 1,379 million |
21
Solid capital position in units and at Group level
Group Solvency II ratio
201% | 208% |
200% | |
Target range | |
150% | |
Year-end | March |
2019 | 31, 2020 |
Group Solvency II ratio at March 31, 2020
- Group Solvency II ratio slightly above the target range supported by normalized capital generation
- Benefit from rising credit spreads, in particular in the Netherlands, were partly offset by adverse market movements in the US
Group Solvency II ratio at the end of April
- Estimated at 190% to 200%
- Mainly driven by narrowing of credit spreads
Solvency II ratio main units at March 31, 2020
- All main units above thebottom-end of their respective target ranges
- Decline in US RBC ratio is mainly due to lower interest rates and equity markets
- Increase in NL Solvency II ratio mainly due to widening of credit spreads
- Stable UK Solvency II ratio reflecting balance sheet light business model
Local solvency ratio by unit
Year-end 2019 and 1Q 2020
US - RBC
470%376%
NL - SII
171% 249%
UK - SII 157% 160%
Notes: 1. Numbers are based on management's best estimates, 2. Bottom-end of the target range US = 350% RBC; bottom-end of the target range NL = 155% Solvency II; bottom-end of | 22 | |
the target range UK = 145% Solvency II |
Protecting the economic value of the balance sheet
Management actions
Hedging and | Underwriting | Capital |
asset allocation | and pricing | preservation |
- Rebalanced macro equity hedge to increase downside protection and control hedging costs towards a more linear protection
- Increasing focus of reinvestments on higher rated credit (>55% A rated or higher) in areas less affected by theCOVID-19 crisis
- Focusing on new issuances in corporate bonds to benefit from higher spreads
- Increasing scrutiny and monitoring in potentiallycrisis-affected asset classes
- Variable annuity repricing in 2Q20 to lead to lower withdrawal rates and lower guarantees
- Launched a new variable annuity product on BaNCS platform with principal protection and upside potential suited for these markets
- Specific new business underwriting requirements introduced, e.g.
- Restricting coverage for new policies for certain age groups in the US
- Postponements of certain coverages with confirmedCOVID-19 exposure in US
- Adjusted underwriting criteria in travel and income protection in Netherlands
- Legal merger of core US Life entities improving asset adequacy testing sufficiency
- Continuing to pursue options for accelerating capital generation in Manage for Value businesses
- Increasing focus on operational excellence to preserve earnings and therewith capital generation, including limiting project and discretionary spend as far as possible
23
Focus on maintaining solid financial position despite challenging conditions
Financial position and outlook
(March 31, 2020)
Group Solvency II ratio
208%
Holding excess cash
EUR 1.4 billion
Return on Equity target
Very unlikely to reach 10%
return on equity target in 2020 given
the extraordinary circumstances
Other medium-term targets
Difficult to provide a full assessment
of COVID-19 related impacts on
medium-term targets
24
Agenda item 3.1 │ Agendapunt 3.1
Reports of the Boards | Verslagen van de |
for 2019 | Raad van Bestuur en de |
Raad van Commissarissen | |
over 2019 |
This item will not be voted upon / Over dit agendapunt wordt niet gestemd | 25 | |
Agenda item 3.2 │ Agendapunt 3.2
Annual Accounts 2019 and | Jaarrekening 2019 en rapport |
report independent auditor | van de onafhankelijke |
accountant |
This item will not be voted upon / Over dit agendapunt wordt niet gestemd | 26 | |
Gert-Jan Heuvelink
15 May 2020
Presentation by PwC
15 May 2020
Audit of Aegon's 2019 Financial Statements
- Audit opinion(refer to pages 328 to 336 of the Annual Report)
- Materiality
- Scope of our group audit
- Risk of fraud andnon-compliance with laws and regulations
- Key audit matters:
- Valuation of certain assets and liabilities arising from insurance contracts
- Valuation of certain level 3 investments
- Uncertainties in policyholder claims and litigation
- Subsequent event procedures /Covid-19 outbreak
- Other information included in the Annual Report
15 May 2020 | |
PwC | 29 |
Agenda item 3.2 │ Agendapunt 3.2
Annual Accounts 2019 and | Jaarrekening 2019 en rapport |
report independent auditor | van de onafhankelijke |
accountant |
This item will not be voted upon / Over dit agendapunt wordt niet gestemd | 30 | |
Agenda item 3.3 │ Agendapunt 3.3
Remuneration Report 2019 | Remuneratierapport 2019 |
This item will be subject to an advisory vote / Over dit agendapunt wordt een adviserende stem uitgebracht | 31 | |
Ben Noteboom
Chairman of the Remuneration Committee
Voorzitter van de Remuneratie Committee
32
Supervisory Board Remuneration Policy 2019
2019 Supervisory Board fees
Fees | Scope |
Base Fee | Supervisory Board membership |
Risk or Audit Committee membership | |
Membership of other Committees | |
Attendance Fee | Committee meetings |
For extra Supervisory Board meetings (>6) | |
Travel Fee | To attend Supervisory Board (Committee) |
meeting | |
Amount(in EUR)
80,000 per year - Chairman
50,000 per year - Vice-Chairman
40,000 per year - Members
13,000 per year - Chairman
8,000 per year - Members
10,000 per year - Chairman
5,000 per year - Members
3,000 per meeting
3,000 per meeting
2,000 for continental or US-interstate travel
4,000 for intercontinental travel
33
Supervisory Board remuneration in 2019
Remuneration received in 2019
In EUR thousands | Base Fee | Attendance Fee | Travel Fee | Total |
Connelly | 95 | 54 | 20 | 169 |
Ellman | 56 | 39 | 20 | 115 |
Noteboom | 58 | 39 | 6 | 103 |
Van der Veer | 58 | 54 | 6 | 118 |
Wortmann - Kool | 63 | 54 | 6 | 123 |
Young | 66 | 66 | 26 | 158 |
Dineen* | 40 | 27 | 12 | 79 |
Total | 436 | 333 | 96 | 865 |
* Up to October 11, 2019 | 34 |
Executive Board Remuneration Policy 2019
Compensation and benefit overview
Component | Details |
Fixed compensation | Paid in monthly installments |
Variable compensation | Target/maximum: 80%/100% of fixed compensation |
Pay-out: | |
•40% upfront | |
•60% deferred, tranche vesting over 3-yr period (3x 20%) | |
•Each portion paid 50:50 in cash/shares | |
•All shares subject to additional 3-year holding period |
Pension | 40% of fixed compensation* | ||
28% of fixed compensation - grandfathered arrangement Mr. Wynaendts | |||
Other benefits | E.g. company car, social security and tax paid by employer | ||
* Up to May 2019, an end of term arrangement applied to Mr. Wynaendts. | 35 |
Executive Board remuneration in 2019
Remuneration received in relation to 2019
In EUR thousands | Fixed | Variable** | Pension | Benefits | Total |
Wynaendts* | 1,314 | 1,048 | 1,302 | 252 | 3,916 |
Rider | 931 | 743 | 373 | 77 | 2,124 |
Total | 2,245 | 1,791 | 1,675 | 329 | 6,040 |
* Pension Mr. Wynaendts: includes Jan-May end of term arrangement, June-Dec 40% of fixed compensation. | 36 |
** Awarded in relation to 2019 performance year (to be paid in 2020-2023). | |
Executive Board variable compensation in 2019
2019 Aegon results for calculation Executive Board variable compensation
37
Executive Board variable compensation in 2019 (cont'd)
2019 results Mr. Wynaendts for variable compensation calculation
38
Executive Board variable compensation in 2019 (cont'd)
2019 results Mr. Rider for variable compensation calculation
39
Executive Board remuneration in 2020
Annualized remuneration levels per January 2020
In EUR thousands | Fixed | Variable | Pension | Total | |
Wynaendts | 1,327 | Target: | 80% | 40% | Target: 3,318 |
+ 2% allowance* | Max: 100% | + 28%* | Max: 3,584 | ||
Friese ** | 1,485 | Target: | 80% | 40% | Target: 3,267 |
Max: 100% | Max: 3,564 | ||||
Rider | 941 | Target: | 80% | 40% | Target: 2,070 |
Max: 100% | Max: 2,258 | ||||
* Grandfathered arrangements (2% allowance and 28% pension).
** When appointed. Received a separate sign-on arrangement of EUR 1.25 mln in March 2020 when hired, which is split in (almost) half cash and the other half in Aegon shares. Half of the sign-on payment has been paid upfront and the other half is deferred to vesting dates in future years.
40
Agenda item 3.3 │ Agendapunt 3.3
Remuneration Report 2019 | Remuneratierapport 2019 |
This item will be subject to an advisory vote / Over dit agendapunt wordt een adviserende stem uitgebracht | 41 | |
Agenda item 3.4 │ Agendapunt 3.4
Adoption of the | Vaststelling van de |
Annual Accounts 2019 | jaarrekening 2019 |
42
Agenda item 3.5 │ Agendapunt 3.5
DividendDividend
This item will not be voted upon / Over dit agendapunt wordt niet gestemd | 43 | |
Dividend
- In its Annual Report 20191), Aegon proposed a final 2019 dividend of EUR 0.16 per common share and EUR 0.004 per common share B, absent further deterioration of the market circumstances, and based on the assessments made at that time
- Subsequently, Aegon decided to forego the 2019 final dividend to comply with the call2)made by EIOPA and DNB
- Therefore, the total dividend for financial year 2019 is the interim dividend of EUR 0.15 per common share and EUR 0.00375 per common share B, paid in September 2019
- Aegon will review opportunities for returning capital to its shareholders as soon as appropriate
- Aegon will take a decision on the 2020 interim dividend in August 2020 in line with our dividend policy, taking circumstances and outlook at that time into consideration
1)The Annual Report 2019 was published on March 18, 2020. | 44 |
- On April 2, 2020, EIOPA and DNB published statements urging insurers to temporarily postpone all dividend distributions.
Agenda item 3.5 │ Agendapunt 3.5
DividendDividend
This item will not be voted upon / Over dit agendapunt wordt niet gestemd | 45 | |
Agenda item 4 │ Agendapunt 4
Release from liability | Kwijting |
46
Agenda item 4.1 │ Agendapunt 4.1
Release from liability for the | Verlenen van kwijting aan de |
members of the | leden van de Raad van Bestuur |
Executive Board for their duties | voor de uitoefening van hun |
performed during 2019 | taak in 2019 |
47
Agenda item 4.2 │ Agendapunt 4.2
Release from liability for the | Verlenen van kwijting aan de |
members of the | leden van de Raad van |
Supervisory Board for their | Commissarissen voor de |
duties performed during 2019 | uitoefening van hun taak in |
2019 |
48
Agenda item 5 │ Agendapunt 5
RemunerationRemuneratie
49
Ben Noteboom
Chairman of the Remuneration Committee
Voorzitter van de Remuneratie Committee
50
Agenda item 5.1 │ Agendapunt 5.1
Adoption of the Remuneration | Vaststelling van het |
Policy for members of the | remuneratiebeleid voor de |
Executive Board | leden van de Raad van Bestuur |
51
Proposed Executive Board Remuneration Policy
Main change 1: Increase alignment with shareholders by increasing shares in pay-mix
Component | Current | Proposed |
Pay-mix of
variable compensation
50% | 33.33% |
in cash | |
in cash | |
50% | 66.67% |
in Aegon | |
in Aegon | shares |
shares | |
52
Proposed Executive Board Remuneration Policy (cont'd)
Main change 2: Simplification by moving from tranche-vesting to cliff-vesting
Component | Current | Proposed | |||||||||||
Vesting schedule of | Yr 0 | +1 | +2 | +3 | +4 | +5 | +6 | Yr 0 | +1 | +2 | +3 | +4 | +5 |
variable compensation | 20% | 33.3% | |||||||||||
20% | 3 years | ||||||||||||
10% | |||||||||||||
10% | 3 years | ||||||||||||
10% | 66.7% | 2 years | |||||||||||
10% | 3 years | ||||||||||||
10% | |||||||||||||
10% | 3 years | ||||||||||||
Cash | Cash | ||||||||||||
Shares | Holding period | Shares | Holding period |
53
Proposed Executive Board Remuneration Policy (cont'd)
Main change 3: Increase long-term focus with introduction 3-year performance period
Component | Current | Proposed | |
Performance period | •1 year for all indicators | • | 3 years for at least 20% of indicators |
• | 1 year for all other indicators | ||
Illustration of proposal
(t-2) | (t-1) | Plan | (t+1) | (t+4) | (t+6) | |
year (t) | ||||||
3-year performance | One variable | 33.33% upfront | ||||
in cash | ||||||
compensation | ||||||
1-yearAllocation | award | Pay-out | 66.67% | 2-year | ||
perfor | - | deferred | ||||
mance | in Aegon | holding period | ||||
for plan year (t) | ||||||
shares | 54 | |||||
Proposed Executive Board Remuneration Policy (cont'd)
Main change 4: Increase transparency and stakeholder alignment with mandatory categories
Component | Current | Proposed | |
Performance indicator | •≥ 50% non-financial (by law) | • | ≥ 50% non-financial (by law) |
mix | • | Mandatory performance indicator | |
categories |
Proposed categories
Category | Examples of performance indicators | |
Shareholders | Relative Total Shareholder Return | |
Capital | Normalized Capital Generation, Solvency II ratio | |
Earnings | Return on Equity, Underlying Earnings, Earnings per Share | |
Sales | Market Consistent Value of New Business, Fees and Premium based Revenues, Annualized Revenue on Deposits | |
Stakeholders | Net Promotor Score, Products per Customer, Employee Training, Employee Turnover | |
ESG | Employee Engagement, Employee Diversity, Risk Management, Governance | |
Strategy | Strategy Execution | 55 |
2020 Executive Board performance indicators
Based on proposed policy changes
2019 performance indicators
2020 performance indicators
Category
Aegon financial
Aegon non- financial
Personal
Performance indicators
Net Deposits
Normalized Capital Generation
Return on Equity
Market Consistent Value of New Business Solvency II ratio
Underlying Earnings Before Tax
New Life Sales
Relational Net Promotor Score
Digitally connected customers
Strategy execution
Control environment
Succession planning
Cultural transformation
Mandatory category | Performance indicators |
Shareholders | Relative TSR |
Capital | Normalized Capital Generation |
Earnings | Return on Equity |
Sales | Market Consistent Value of New Business |
Fees and Premium based Revenues | |
Stakeholders | Relational Net Promotor Score |
Strategy | Execution of key strategic projects |
Personal indicators: CEO handover, strategy | |
execution and transformation projects | |
ESG | Personal indicators: employee engagement, |
diversity & inclusion and control environment |
56
Proposed Executive Board Remuneration Policy (cont'd)
Summary of main remuneration elements
Component | Details |
Total remuneration | •Internal references: Management Board and general employee |
level | population |
•External references: market trends, inflation, European insurance | |
peer group, Dutch AEX peer group | |
Fixed compensation | •Base Fee: In cash, optionally in shares |
Variable compensation | •Target: 80% of fixed compensation |
•Maximum: 100% of fixed compensation | |
•Subject to collective plan rules, incl. malus and claw back clauses | |
Pension | •40% of fixed compensation |
Other benefits | •E.g. company car, social security and tax paid by employer. |
57
Agenda item 5.2 │ Agendapunt 5.2
Adoption of the Remuneration | Vaststelling van het |
Policy for members of the | remuneratiebeleid voor de |
Supervisory Board | leden van de |
Raad van Commissarissen |
58
Proposed Supervisory Board Remuneration Policy
Main policy changes
Component | Current |
Fees | •2019 fee |
levels |
Policy-considerations | •Not included |
Proposed
- No change to 2019 Fee levels
- Option to index the Fees each year for economic developments (e.g. inflation)
- Any Fee change exceeding this level or change in the scope of a Fee, still requires Shareholder approval
- Explanation how the Policy contributes to Aegon's strategy,long-term interests and sustainability
- Explanation how the Supervisory Board took Aegon's identity, purpose, values and stakeholder environment into account when drafting the Policy
59
Agenda item 5 │ Agendapunt 5
RemunerationRemuneratie
60
Agenda item 6 │ Agendapunt 6
Composition of the | Samenstelling van de |
Supervisory Board | Raad van Commissarissen |
61
Agenda item 6.1 │ Agendapunt 6.1
Appointment of Mr. Thomas | Benoeming van de heer |
Wellauer as member of the | Thomas Wellauer als lid van de |
Supervisory Board | Raad van Commissarissen |
62
Thomas Wellauer
- Age: 64
- Nationality: Swiss
- Main occupation
- Non-executivedirector
- Main former occupation
- COO of Swiss Re
- Membership of other Boards
- Chairman of the Board of Directors of SIX(non-listed)
- Chairman of the Board of Trustees of the University Hospital Zurich Foundation(non-listed)
- Member of the Global Executive Board of the International Chamber of Commerce(non-listed)*
* The board membership at International Chamber of Commerce will end on June 30, 2020 | 63 | |
Agenda item 6.1 │ Agendapunt 6.1
Appointment of Mr. Thomas | Benoeming van de heer |
Wellauer as member of the | Thomas Wellauer als lid van de |
Supervisory Board | Raad van Commissarissen |
64
Agenda item 6.2 │ Agendapunt 6.2
Appointment of Mrs. Caroline | Benoeming van mevrouw |
Ramsay as member of the | Caroline Ramsay als lid van de |
Supervisory Board | Raad van Commissarissen |
65
Caroline Ramsay
- Age: 57
- Nationality: British
- Main occupation
- Senior finance and audit roles in Financial Services
- Main former occupation
- Group Chief Auditor of RSA plc.
- Membership of other Boards
- Non-ExecutiveAudit Committee Chair of Brit Syndicates Ltd. (non-listed)
- Non-ExecutiveAudit Committee Chair of Standard Life UK Smaller Companies Trust plc.
- Non-ExecutiveAudit Committee Chair of Tesco Underwriting Ltd. (non-listed)
- Member of FCA Regulatory Decisions Committee and Member of the Payment Systems Regulator Enforcement Decisions Committee(non-listed)
- Non-ExecutiveAudit Committee Chair of Scottish Equitable plc., Aegon UK, and Cofunds Ltd. (non-listed)*
* The board memberships at Scottish Equitable plc., Aegon UK, and Cofunds Ltd. will end should Mrs. Ramsay be | 66 | |
appointed to the Supervisory Board of Aegon N.V. | ||
Agenda item 6.2 │ Agendapunt 6.2
Appointment of Mrs. Caroline | Benoeming van mevrouw |
Ramsay as member of the | Caroline Ramsay als lid van de |
Supervisory Board | Raad van Commissarissen |
67
Agenda item 7 │ Agendapunt 7
Composition of the | Samenstelling van de |
Executive Board | Raad van Bestuur |
68
Agenda item 7.1 │ Agendapunt 7.1
Appointment of Mr. Lard Friese | Benoeming van de heer |
as member of the | Lard Friese als lid van de |
Executive Board | Raad van Bestuur |
69
Lard Friese
- Age: 57
- Nationality: Dutch
- Shares in the company:
- None
- Main former occupation:
- Chair of the Executive Board and CEO of NN Group
- External Board membership that qualify under Act Management and Supervision:
- None
70
Agenda item 7.1 │ Agendapunt 7.1
Appointment of Mr. Lard Friese | Benoeming van de heer |
as member of the | Lard Friese als lid van de |
Executive Board | Raad van Bestuur |
71
Agenda item 8 │ Agendapunt 8
Cancellation, issuance, and | Intrekking, uitgifte en verkrijging |
acquisition of shares | van aandelen |
72
Agenda item 8 │ Agendapunt 8
- Proposal to cancel common shares and common shares B
- Authorization of the Executive Board to issue common shares with or withoutpre-emptive rights
- Authorization of the Executive Board to issue shares in connection with a rights issue
- Authorization of the Executive Board to acquire shares in the Company
-
Voorstel tot intrekking van gewone aandelen en gewone aandelen B
Machtiging van de Raad van Bestuur tot uitgifte - van gewone aandelen met of zonder voorkeursrechten
Machtiging van de Raad van Bestuur tot uitgifte - van gewone aandelen in verband met een claimemissie
- Machtiging van de Raad van Bestuur tot verkrijging van eigen aandelen door de Vennootschap
73
Agenda item 9 │ Agendapunt 9
Any other business | Wat verder ter tafel komt |
This item will not be voted upon / Over dit agendapunt wordt niet gestemd | 74 | |
Agenda item 10 │ Agendapunt 10
ClosingSluiting
This item will not be voted upon / Over dit agendapunt wordt niet gestemd | 75 | |
Attachments
- Original document
- Permalink
Disclaimer
AEGON NV published this content on 14 May 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 May 2020 08:09:03 UTC